Interferon-γ Promotes Antibody-mediated Fratricide of Acute Myeloid Leukemia Cells

Decitabine enhances anti-CD33 monoclonal antibody BI 836858-mediated natural killer ADCC against AML blasts

(2016) S. Vasu et al.   BLOOD

The addition of gemtuzumab ozogamicin to chemotherapy in adult patients with acute myeloid leukemia

(2016) Jonathan Kell   Expert Review of Anticancer Therapy

Monoclonal antibodies targeting CD38 in hematological malignancies and beyond

(2016) Niels W. C. J. van de Donk et al.   IMMUNOLOGICAL REVIEWS

Type I IFN promotes NK cell expansion during viral infection by protecting NK cells against fratricide

(2016) Sharline Madera et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Introduction to the review series on advances in acute myeloid leukemia (AML)

(2015) B. Lowenberg et al.   BLOOD

Emerging therapeutic drugs for AML

(2015) E. M. Stein et al.   BLOOD

Current challenges in clinical development of "targeted therapies": the case of acute myeloid leukemia

(2015) E. Estey et al.   BLOOD

An update of current treatments for adult acute myeloid leukemia

(2015) H. Dombret et al.   BLOOD

Granzyme B Expression Is Enhanced in Human Monocytes by TLR8 Agonists and Contributes to Antibody-Dependent Cellular Cytotoxicity

(2015) Saranya Elavazhagan et al.   JOURNAL OF IMMUNOLOGY

Upregulation of CD38 expression on multiple myeloma cells by all-trans retinoic acid improves the efficacy of daratumumab

(2015) I S Nijhof et al.   LEUKEMIA

Acute Myeloid Leukemia

(2015) Hartmut Döhner et al.   NEW ENGLAND JOURNAL OF MEDICINE

Targeting CD38 with Daratumumab Monotherapy in Multiple Myeloma

(2015) Henk M. Lokhorst et al.   NEW ENGLAND JOURNAL OF MEDICINE

Agonist antibody that induces human malignant cells to kill one another

(2015) Kyungmoo Yea et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Targeting the Innate Immune System as Immunotherapy for Acute Myeloid Leukemia

(2015) Emily Curran et al.   Frontiers in Oncology

Targeting of acute myeloid leukemia in vitro and in vivo with an anti-CD123 mAb engineered for optimal ADCC

(2014) S J Busfield et al.   LEUKEMIA

NK-cell fratricide: Dynamic crosstalk between NK and cancer cells

(2014) Kyohei Nakamura et al.   OncoImmunology

SGN-CD33A: a novel CD33-targeting antibody-drug conjugate using a pyrrolobenzodiazepine dimer is active in models of drug-resistant AML

(2013) M. S. Kung Sutherland et al.   BLOOD

TLR-mediated activation of NK cells and their role in bacterial/viral immune responses in mammals

(2013) Minou Adib-Conquy et al.   IMMUNOLOGY AND CELL BIOLOGY

Preclinical activity of a novel CRM1 inhibitor in acute myeloid leukemia

(2012) P. Ranganathan et al.   BLOOD

The application of Toll like receptors for cancer therapy

(2012) Eui Young So et al.   International Journal of Biological Sciences

Functional Characteristics of the High Affinity IgG Receptor, Fc RI

(2011) C. E. van der Poel et al.   JOURNAL OF IMMUNOLOGY

Identification and manipulation of tumor associated macrophages in human cancers

(2011) Moniek Heusinkveld et al.   Journal of Translational Medicine

Allogeneic hematopoietic cell transplantation for adults with acute myeloid leukemia: myths, controversies, and unknowns

(2010) V. Gupta et al.   BLOOD

Reciprocal Regulation of Activating and Inhibitory Fc  Receptors by TLR7/8 Activation: Implications for Tumor Immunotherapy

(2010) J. P. Butchar et al.   CLINICAL CANCER RESEARCH

Daratumumab, a Novel Therapeutic Human CD38 Monoclonal Antibody, Induces Killing of Multiple Myeloma and Other Hematological Tumors

(2010) M. de Weers et al.   JOURNAL OF IMMUNOLOGY

The battlefield of perforin/granzyme cell death pathways

(2009) Sabine Hoves et al.   JOURNAL OF LEUKOCYTE BIOLOGY